Majestic Research

What could you do with exclusive, real-time knowledge of the key metrics driving financial performance from individual companies to the entire pharmaceutical and biotech sector?  Majestic provides deep insight into all major prescription drugs. Our written prescription data from over 3,500 physicians across nine different specialties provides: Important promotional activity and prescription trends. Granular treatment usage information on a patient-specific basis. Transparency in new drug launches and changes in prescription trends. Usage resulting from major events that are not as apparent in pharmacy-level prescription data alone.

Data

Over 6,000 medical specialists across nine different networks: PCPs, cardiologists, endocrinologists, gastroenterologists, neurologists, psychiatrists, rheumatologists, urologists, and oncologists. Written Rx data includes patient diagnosis and demographics, new and renewal Rx share, product sampling rates, switch reason verbatims, and several other treatment-related variables. Dispensed Rx data includes date of administration and quantity of drug dispensed. Additionally, we collect data on how companies are marketing their drugs, what their share of physician attention is, and how their detailing translates into new written scripts. Our proprietary data in the oncology space includes granular dispensing data from over 600 oncology clinics nationwide, representing over 2,500 oncology specialists, 80,000 cancer patients, and about 780,000 clinic visits per month.

Therapeutic Areas Under Coverage

Oncology: Acute Myeloid Leukemia, Brain Cancer, Breast Cancer, Chronic Lymphocytic Leukemia, Colorectal Cancer, Kidney Cancer, Liver Cancer, Multiple Myeloma, Myelodysplastic Syndrome, Non-Hodgkin’s Lymphoma, Non-Small Cell Lung Cancer, Ovarian Cancer

Non-Oncology: Attention Deficit Disorder Depression, Cardiovascular Disease, Diabetes, Fibromyalgia, Gastrointestinal Disorders, Insomnia, Multiple Sclerosis, Overactive Bladder, Pain, Psoriasis, Rheumatoid Arthritis

Delivered Information

In our custom reports, we analyze drug data for:

• Market share for different drugs
• Drug switching activity
• Line of therapy (oncology drugs)
• Off-label usage
• Patient demographics
• Sampling rate
• Diagnosis breakdown for drugs approved for multiple indications